help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 4, No. 2 276-286
doi:10.1210/mend-4-2-276
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curtis, S. W.
Right arrow Articles by Korach, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtis, S. W.
Right arrow Articles by Korach, K. S.

Uterine Estrogen Receptor Interaction with Estrogen-Responsive DNA Sequences in Vitro: Effects of Ligand Binding on Receptor-DNA Complexes

Sylvia W. Curtis and Kenneth S. Korach

Receptor Biology Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences Research Triangle Park, North Carolina 27709

Address requests for reprints to: Dr. Kenneth S. Korach, National Institute of Environmental Health Sciences, Receptor Biology Section, Laboratory of Reproductive and Developmental Toxicology, P.O. Box 12233, Research Triangle Park, North Carolina 27709.

Abstract

Interaction between the mouse estrogen receptor (ER) and its responsive element (ERE) were examined in vitro using tissue extracts and an oligonucleotide containing a Vitellogenin A2 ERE (VRE) in a gel retardation assay. Three specific complexes were formed when nuclear extracts were prepared from estrogen agonist-treated uteri or when ligandfree ER from cytosol was used. ER protein was associated with the three complexes, as demonstrated by their ability to bind anti-ER antibody H222. Specific complexes were formed only when double stranded nonheat-denatured VRE was used. Mutation of the ERE in VRE abolished specific binding. The complexes formed by nuclear extracts were qualitatively identical when obtained from mice treated with a variety of estrogenic compounds with different potencies. Nuclear extracts obtained from mice treated with an estrogen antagonist LY117018 formed complexes that migrated slower than the complexes formed by the other estrogenic compounds examined. The dissociation rates (k–1) and equilibrium dissociation constants (Kd) of the ERVRE complexes formed by estradiol- or estriolbound ER or ligand-free ER were measured and were found to be very similar, although the ligandfree specific ER complexes associate and dissociate less rapidly than those of estradiol- or estriolbound ER. In addition, one of the specific complexes formed by the estriol nuclear extract dissociated more slowly than the equivalent estradiol complex. Heat activating ligand-free ER did not increase its binding to VRE. It appears that the ligand-binding domain of the ER does not exert its regulatory effects at the level of sequence-specific DNA binding, since its occupancy does not alter binding to the ERE. The subtle differences we observed in association and dissociation of multiple complexes when unoccupied ER and ER boundto ligands of varying potencies are compared may reflect differences in ER association with other protein factors that govern transcriptional activity.

Received for publication October 4, 1989. Revision received November 13, 1989. Accepted for publication November 13, 1989.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
M. A. Loven, N. Muster, J. R. Yates, and A. M. Nardulli
A Novel Estrogen Receptor {alpha}-Associated Protein, Template-Activating Factor I{beta}, Inhibits Acetylation and Transactivation
Mol. Endocrinol., January 1, 2003; 17(1): 67 - 78.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. A. Peters and S. A. Khan
Estrogen Receptor Domains E and F: Role in Dimerization and Interaction with Coactivator RIP-140
Mol. Endocrinol., February 1, 1999; 13(2): 286 - 296.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. Migliaccio, T. F. Washburn, S. Fillo, H. Rivera, A. Teti, K. S. Korach, and W. C. Wetsel
Modulation of Estrogen Receptor Levels in Mouse Uterus by Protein Kinase C Isoenzymes
Endocrinology, November 1, 1998; 139(11): 4598 - 4606.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Santagati, E. Gianazza, P. Agrati, E. Vegeto, C. Patrone, G. Pollio, and A. Maggi
Oligonucleotide Squelching Reveals the Mechanism of Estrogen Receptor Autologous Down-Regulation
Mol. Endocrinol., June 1, 1997; 11(7): 938 - 949.
[Abstract] [Full Text]


Home page
CirculationHome page
C. D. Venkov, A. B. Rankin, and D. E. Vaughan
Identification of Authentic Estrogen Receptor in Cultured Endothelial Cells: A Potential Mechanism for Steroid Hormone Regulation of Endothelial Function
Circulation, August 15, 1996; 94(4): 727 - 733.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Wang, G. A. Peters, X. Zeng, M. Tang, W. Ip, and S. A. Khan
Yeast Two-hybrid System Demonstrates That Estrogen Receptor Dimerization Is Ligand-dependent in Vivo
J. Biol. Chem., October 6, 1995; 270(40): 23322 - 23329.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Hyder, Z. Nawaz, C. Chiappetta, K. Yokoyama, and G. M. Stancel
The Protooncogene c- jun Contains an Unusual Estrogen-inducible Enhancer within the Coding Sequence
J. Biol. Chem., April 14, 1995; 270(15): 8506 - 8513.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society